Premium
CLINICAL AND RADIOGRAPHIC FACTORS PRIOR TO CAR T‐CELL THERAPY ACCURATELY IDENTIFY RELAPSED/REFRACTORY LYMPHOMA PATIENTS AT HIGH RISK FOR PROGRESSION AND POOR SURVIVAL
Author(s) -
Jodon G.,
Colton M. D.,
Cai A. R.,
Haverkos B.,
Morgan R.,
Kamdar M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.91_2881
Subject(s) - medicine , proportional hazards model , lymphoma , refractory (planetary science) , oncology , aggressive lymphoma , retrospective cohort study , progression free survival , salvage therapy , surgery , chemotherapy , rituximab , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom